Transparent and institutionally strong pharmaceutical supply chains can
strongly contribute towards improving access to essential drugs. However,
pharmaceutical supply and distribution systems in most countries are often a
complex network of heterogeneous stake-holders from the public,
private-for-profit and private-non-profit sectors. The purpose of this report is
to provide an overview of the different players, their roles and functions
within the public sector, the private sector and the mission sector supply chain
for medicines in Zambia. We present these supply chain maps with additional
considerations on possible entry points for the MeTA initiative within the
various functions outlined in this report.
The methodology used for this study consisted of primarily qualitative and
some quantitative analysis. The study traces the flow of essential medicines
from the manufacturer to the patient in the three sectors outlined above.
Primary research was conducted using in-person interviews with various
stake-holders in the supply chain in Zambia. A template to assess role and
responsibilities and the extent of markups at each stage was used wherever
possible. This initial study was used to assess the feasibility and value of a
detailed supply chain mapping exercise for the MeTA initiative. This should be
viewed as a preliminary-level study as all information could not be obtained in
the short time frame.